Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3
BCR-ABL1
case report
chronic myeloid leukemia
e14a3
nilotinib
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
29
01
2019
accepted:
15
05
2019
entrez:
13
8
2019
pubmed:
14
8
2019
medline:
14
8
2019
Statut:
ppublish
Résumé
We report a case of chronic myeloid leukemia in a 52-year-old male expressing a rare e14a3
Identifiants
pubmed: 31404304
doi: 10.3892/ol.2019.10558
pii: OL-0-0-10558
pmc: PMC6676706
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2648-2653Références
Cancer Res. 2001 Mar 15;61(6):2343-55
pubmed: 11289094
Mol Cell. 2003 Jul;12(1):27-37
pubmed: 12887890
Am J Hematol. 2004 Feb;75(2):92-5
pubmed: 14755375
Nat Rev Cancer. 2005 Mar;5(3):172-83
pubmed: 15719031
Leukemia. 2005 Dec;19(12):2334-6
pubmed: 16224485
Leuk Res. 2008 Apr;32(4):579-85
pubmed: 17928051
Int J Hematol. 2008 Mar;87(2):184-188
pubmed: 18253707
Int J Cancer. 2009 Jun 1;124(11):2539-48
pubmed: 19173293
J Mol Diagn. 2009 Jul;11(4):359-63
pubmed: 19497989
Acta Oncol. 2010 May;49(4):506-8
pubmed: 20331405
PLoS One. 2011 Feb 11;6(2):e17020
pubmed: 21347248
Methods Mol Med. 1996;6:25-36
pubmed: 21380694
Acta Haematol. 2011;126(4):205-10
pubmed: 21934293
Acta Haematol. 2012;127(1):7-9
pubmed: 21986290
Leuk Res. 2012 Sep;36(9):1208-9
pubmed: 22726921
Mol Cancer Ther. 2013 Jun;12(6):1085-98
pubmed: 23536723
FASEB J. 2014 Mar;28(3):1221-36
pubmed: 24297701
Carcinogenesis. 2014 May;35(5):1132-43
pubmed: 24445143
Leuk Lymphoma. 2015;56(12):3343-7
pubmed: 25962435
Leukemia. 2016 Jan;30(1):57-64
pubmed: 26437782
PLoS One. 2015 Oct 16;10(10):e0140585
pubmed: 26473951
Curr Cancer Drug Targets. 2016;16(7):594-605
pubmed: 26728039
Expert Rev Anticancer Ther. 2016;16(3):273-8
pubmed: 26852913
J Clin Oncol. 2016 Jul 10;34(20):2333-40
pubmed: 27217448
N Engl J Med. 2017 Mar 9;376(10):917-927
pubmed: 28273028
Leuk Res Rep. 2017 Jan 31;7:17-19
pubmed: 28275539
Clin Cancer Res. 2017 Dec 1;23(23):7189-7198
pubmed: 28928163
J Clin Oncol. 2018 Jan 20;36(3):231-237
pubmed: 29091516
Oncol Lett. 2017 Nov;14(5):5619-5623
pubmed: 29113191
Oncol Lett. 2018 Feb;15(2):2491-2494
pubmed: 29434963
Mol Cancer. 2018 Feb 19;17(1):56
pubmed: 29455672
Case Rep Oncol. 2018 Jul 16;11(2):485-492
pubmed: 30140211